{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:43Z","timestamp":1787166703260,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD083092"],"award-info":[{"award-number":["U54HD083092"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD055651"],"award-info":[{"award-number":["R01HD055651"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genet"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00439-019-02088-4","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T14:37:11Z","timestamp":1574347031000},"page":"1121-1130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The current and future impact of genome-wide sequencing on fetal precision medicine"],"prefix":"10.1007","volume":"139","author":[{"given":"Riwa","family":"Sabbagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-5924","authenticated-orcid":false,"given":"Ignatia B.","family":"Van den Veyver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,21]]},"reference":[{"key":"2088_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/pd.5038","volume":"38","author":"AN Abou Tayoun","year":"2018","unstructured":"Abou Tayoun AN, Spinner NB, Rehm HL, Green RC, Bianchi DW (2018) Prenatal DNA sequencing: clinical, counseling, and diagnostic laboratory considerations. Prenat Diagn 38:26\u201332. https:\/\/doi.org\/10.1002\/pd.5038","journal-title":"Prenat Diagn"},{"key":"2088_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/uog.14636","volume":"45","author":"R Akolekar","year":"2015","unstructured":"Akolekar R, Beta J, Picciarelli G, Ogilvie C, D\u2019Antonio F (2015) Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 45:16\u201326. https:\/\/doi.org\/10.1002\/uog.14636","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2088_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/gim.2014.151","volume":"17","author":"American College of Medical Genetics and Genomics (ACMG) Board of Directors","year":"2015","unstructured":"American College of Medical Genetics and Genomics (ACMG) Board of Directors (2015) ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 17:68\u201369. https:\/\/doi.org\/10.1038\/gim.2014.151","journal-title":"Genet Med"},{"key":"2088_CR4","unstructured":"American College of Obstetrics and Gynecology (ACOG) (2019) Practice Advisory Cell-free DNA to Screen for Single-Gene Disorders. https:\/\/www.acog.org\/Clinical-Guidance-and-Publications\/Practice-Advisories\/Cell-free-DNA-to-Screen-for-Single-Gene-Disorders. Accessed 21 Feb 2019"},{"key":"2088_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/aog.0000000000001438","volume":"127","author":"American College of Obstetrics and Gynecology (ACOG) Committee on Genetics","year":"2016","unstructured":"American College of Obstetrics and Gynecology (ACOG) Committee on Genetics (2016a) Practice Bulletin No. 162 Summary: prenatal diagnostic testing for genetic disorders. Obstet Gynecol 127:976\u2013978. https:\/\/doi.org\/10.1097\/aog.0000000000001438","journal-title":"Obstet Gynecol"},{"key":"2088_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/aog.0000000000001439","volume":"127","author":"American College of Obstetrics and Gynecology (ACOG) Committee on Genetics","year":"2016","unstructured":"American College of Obstetrics and Gynecology (ACOG) Committee on Genetics (2016b) Practice Bulletin No. 163 Summary: screening for fetal aneuploidy. Obstet Gynecol 127:979\u2013981. https:\/\/doi.org\/10.1097\/aog.0000000000001439","journal-title":"Obstet Gynecol"},{"key":"2088_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","volume":"20","author":"SE Antonarakis","year":"2019","unstructured":"Antonarakis SE (2019) Carrier screening for recessive disorders. Nat Rev Genet 20:549\u2013561. https:\/\/doi.org\/10.1038\/s41576-019-0134-2","journal-title":"Nat Rev Genet"},{"key":"2088_CR8","first-page":"677","volume":"42","author":"PA Baird","year":"1988","unstructured":"Baird PA, Anderson TW, Newcombe HB, Lowry RB (1988) Genetic disorders in children and young adults: a population study. Am J Hum Genet 42:677\u2013693","journal-title":"Am J Hum Genet"},{"key":"2088_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/ajmg.c.31487","volume":"172","author":"AL Beaudet","year":"2016","unstructured":"Beaudet AL (2016) Using fetal cells for prenatal diagnosis: History and recent progress. Am J Med Genet C 172:123\u2013127. https:\/\/doi.org\/10.1002\/ajmg.c.31487","journal-title":"Am J Med Genet C"},{"key":"2088_CR10","doi-asserted-by":"publisher","first-page":"65ra64","DOI":"10.1126\/scitranslmed.3001756","volume":"3","author":"CJ Bell","year":"2011","unstructured":"Bell CJ et al (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3:65ra64. https:\/\/doi.org\/10.1126\/scitranslmed.3001756","journal-title":"Sci Transl Med"},{"key":"2088_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/pd.5102","volume":"38","author":"S Best","year":"2018","unstructured":"Best S, Wou K, Vora N, Van den Veyver IB, Wapner R, Chitty LS (2018) Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn 38:10\u201319. https:\/\/doi.org\/10.1002\/pd.5102","journal-title":"Prenat Diagn"},{"key":"2088_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1056\/NEJMra1705345","volume":"379","author":"DW Bianchi","year":"2018","unstructured":"Bianchi DW, Chiu RWK (2018) Sequencing of circulating cell-free DNA during pregnancy. N Engl J Med 379:464\u2013473. https:\/\/doi.org\/10.1056\/NEJMra1705345","journal-title":"N Engl J Med"},{"key":"2088_CR13","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1056\/NEJMc1408914","volume":"371","author":"LG Biesecker","year":"2014","unstructured":"Biesecker LG, Green RC (2014) Diagnostic clinical genome and exome sequencing. N Engl J Med 371:1170. https:\/\/doi.org\/10.1056\/NEJMc1408914","journal-title":"N Engl J Med"},{"issue":"S1","key":"2088_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/uog.17084","volume":"48","author":"LS Chitty","year":"2016","unstructured":"Chitty LS, David AL, Gottschalk I, Oepkes D, Westgren M, G\u00f6therstr\u00f6m C, Consortium O (2016) EP21.04. BOOSTB4: clinical study to determine safety and efficacy of pre- and\/or postnatal stem cell transplantation for treatment of osteogenesis imperfecta. Ultrasound Obstet Gynecol 48(S1):356. https:\/\/doi.org\/10.1002\/uog.17084","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2088_CR15","doi-asserted-by":"publisher","first-page":"20458","DOI":"10.1073\/pnas.0810641105","volume":"105","author":"RW Chiu","year":"2008","unstructured":"Chiu RW et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105:20458\u201320463. https:\/\/doi.org\/10.1073\/pnas.0810641105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2088_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.222","author":"D Chokoshvili","year":"2017","unstructured":"Chokoshvili D, Borry P, Vears DF (2017) A systematic analysis of online marketing materials used by providers of expanded carrier screening. Genet Med. https:\/\/doi.org\/10.1038\/gim.2017.222","journal-title":"Genet Med"},{"key":"2088_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","volume":"3","author":"MM Clark","year":"2018","unstructured":"Clark MM, Stark Z, Farnaes L, Tan TY, White SM, Dimmock D, Kingsmore SF (2018) Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. NPJ Genom Med 3:16. https:\/\/doi.org\/10.1038\/s41525-018-0053-8","journal-title":"NPJ Genom Med"},{"key":"2088_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1471-0528.12382","volume":"121","author":"RK Dhillon","year":"2014","unstructured":"Dhillon RK, Hillman SC, Morris RK, McMullan D, Williams D, Coomarasamy A, Kilby MD (2014) Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis. BJOG 121:11\u201321. https:\/\/doi.org\/10.1111\/1471-0528.12382","journal-title":"BJOG"},{"key":"2088_CR19","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/pd.4675","volume":"35","author":"S Drury","year":"2015","unstructured":"Drury S et al (2015) Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn 35:1010\u20131017. https:\/\/doi.org\/10.1002\/pd.4675","journal-title":"Prenat Diagn"},{"key":"2088_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-319-42044-8_14","volume":"924","author":"S Drury","year":"2016","unstructured":"Drury S, Mason S, McKay F, Lo K, Boustred C, Jenkins L, Chitty LS (2016) Implementing non-invasive prenatal diagnosis (NIPD) in a national health service laboratory; From Dominant to Recessive Disorders. Adv Exp Med Biol 924:71\u201375. https:\/\/doi.org\/10.1007\/978-3-319-42044-8_14","journal-title":"Adv Exp Med Biol"},{"key":"2088_CR21","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.1016\/j.ajog.2003.10.174","volume":"189","author":"K Eddleman","year":"2003","unstructured":"Eddleman K et al (2003) Pregnancy loss rates after midtrimester amniocentesis: the faster trial. Am J Obstet Gynecol 189:S111","journal-title":"Am J Obstet Gynecol"},{"key":"2088_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/AOG.0000000000000666","volume":"125","author":"JG Edwards","year":"2015","unstructured":"Edwards JG et al (2015) Expanded carrier screening in reproductive medicine-points to consider: a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol 125:653\u2013662. https:\/\/doi.org\/10.1097\/AOG.0000000000000666","journal-title":"Obstet Gynecol"},{"key":"2088_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ajog.2016.04.029","volume":"215","author":"MI Evans","year":"2016","unstructured":"Evans MI, Wapner RJ, Berkowitz RL (2016) Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor. Am J Obstet Gynecol 215:298\u2013305. https:\/\/doi.org\/10.1016\/j.ajog.2016.04.029","journal-title":"Am J Obstet Gynecol"},{"key":"2088_CR24","doi-asserted-by":"publisher","first-page":"16266","DOI":"10.1073\/pnas.0808319105","volume":"105","author":"HC Fan","year":"2008","unstructured":"Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105:16266\u201316271. https:\/\/doi.org\/10.1073\/pnas.0808319105","journal-title":"Proc Natl Acad Sci USA"},{"key":"2088_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature11251","volume":"487","author":"HC Fan","year":"2012","unstructured":"Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR (2012) Non-invasive prenatal measurement of the fetal genome. Nature 487:320\u2013324. https:\/\/doi.org\/10.1038\/nature11251","journal-title":"Nature"},{"key":"2088_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/pd.4464","volume":"35","author":"I Filges","year":"2015","unstructured":"Filges I, Friedman JM (2015) Exome sequencing for gene discovery in lethal fetal disorders\u2014harnessing the value of extreme phenotypes. Prenat Diagn 35:1005\u20131009. https:\/\/doi.org\/10.1002\/pd.4464","journal-title":"Prenat Diagn"},{"key":"2088_CR27","first-page":"745","volume":"57","author":"JM Friedman","year":"1981","unstructured":"Friedman JM (1981) Genetic disease in the offspring of older fathers. Obstet Gynecol 57:745\u2013749","journal-title":"Obstet Gynecol"},{"key":"2088_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/uog.14791","volume":"45","author":"MM Gil","year":"2015","unstructured":"Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH (2015) Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 45:249\u2013266. https:\/\/doi.org\/10.1002\/uog.14791","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2088_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5532","author":"KJ Gray","year":"2019","unstructured":"Gray KJ, Wilkins-Haug LE, Herrig NJ, Vora NL (2019) Fetal phenotypes emerge as genetic technologies become robust. Prenat Diagn. https:\/\/doi.org\/10.1002\/pd.5532","journal-title":"Prenat Diagn"},{"key":"2088_CR30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC et al (2013) ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15:565\u2013574. https:\/\/doi.org\/10.1038\/gim.2013.73","journal-title":"Genet Med"},{"key":"2088_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.semperi.2018.07.019","volume":"42","author":"AR Gregg","year":"2018","unstructured":"Gregg AR, Edwards JG (2018) Prenatal genetic carrier screening in the genomic age. Semin Perinatol 42:303\u2013306. https:\/\/doi.org\/10.1053\/j.semperi.2018.07.019","journal-title":"Semin Perinatol"},{"key":"2088_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.siny.2017.12.002","volume":"23","author":"J Hayward","year":"2018","unstructured":"Hayward J, Chitty LS (2018) Beyond screening for chromosomal abnormalities: advances in non-invasive diagnosis of single gene disorders and fetal exome sequencing. Semin Fetal Neonatal Med 23:94\u2013101. https:\/\/doi.org\/10.1016\/j.siny.2017.12.002","journal-title":"Semin Fetal Neonatal Med"},{"key":"2088_CR33","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/ejhg.2015.271","volume":"24","author":"L Henneman","year":"2016","unstructured":"Henneman L et al (2016) Responsible implementation of expanded carrier screening. Eur J Hum Genet 24:e1\u2013e12. https:\/\/doi.org\/10.1038\/ejhg.2015.271","journal-title":"Eur J Hum Genet"},{"key":"2088_CR34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/uog.12464","volume":"41","author":"SC Hillman","year":"2013","unstructured":"Hillman SC et al (2013) Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 41:610\u2013620. https:\/\/doi.org\/10.1002\/uog.12464","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2088_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/pd.5195","volume":"38","author":"ISPD, SMFM, PQF","year":"2018","unstructured":"ISPD, SMFM, PQF (2018) Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis. Prenat Diagn 38:6\u20139. https:\/\/doi.org\/10.1002\/pd.5195","journal-title":"Prenat Diagn"},{"key":"2088_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/gim.2016.190","volume":"19","author":"SS Kalia","year":"2017","unstructured":"Kalia SS et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19:249\u2013255. https:\/\/doi.org\/10.1038\/gim.2016.190","journal-title":"Genet Med"},{"key":"2088_CR37","doi-asserted-by":"publisher","first-page":"137ra176","DOI":"10.1126\/scitranslmed.3004323","volume":"4","author":"JO Kitzman","year":"2012","unstructured":"Kitzman JO et al (2012) Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 4:137ra176. https:\/\/doi.org\/10.1126\/scitranslmed.3004323","journal-title":"Sci Transl Med"},{"key":"2088_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature11396","volume":"488","author":"A Kong","year":"2012","unstructured":"Kong A et al (2012) Rate of de novo mutations and the importance of father\u2019s age to disease risk. Nature 488:471\u2013475. https:\/\/doi.org\/10.1038\/nature11396","journal-title":"Nature"},{"key":"2088_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pd.4532","volume":"35","author":"S Langlois","year":"2015","unstructured":"Langlois S, Benn P, Wilkins-Haug L (2015) Current controversies in prenatal diagnosis 4: pre-conception expanded carrier screening should replace all current prenatal screening for specific single gene disorders. Prenat Diagn 35:23\u201328. https:\/\/doi.org\/10.1002\/pd.4532","journal-title":"Prenat Diagn"},{"key":"2088_CR40","first-page":"107","volume":"2","author":"JE Larson","year":"2000","unstructured":"Larson JE, Cohen JC (2000) In utero gene therapy. Ochsner J 2:107\u2013110","journal-title":"Ochsner J"},{"key":"2088_CR41","doi-asserted-by":"publisher","first-page":"227.e216","DOI":"10.1016\/j.ajog.2016.02.030","volume":"215","author":"RB Lefkowitz","year":"2016","unstructured":"Lefkowitz RB et al (2016) Clinical validation of a non-invasive prenatal test for genome-wide detection of fetal copy number variants. Am J Obstet Gynecol 215:227.e216\u2013227.e221. https:\/\/doi.org\/10.1016\/j.ajog.2016.02.030","journal-title":"Am J Obstet Gynecol"},{"key":"2088_CR42","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485\u2013487","journal-title":"Lancet"},{"key":"2088_CR43","doi-asserted-by":"publisher","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","volume":"2","author":"YM Lo","year":"2010","unstructured":"Lo YM et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91. https:\/\/doi.org\/10.1126\/scitranslmed.3001720","journal-title":"Sci Transl Med"},{"key":"2088_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/s0140-6736(18)31940-8","volume":"393","author":"J Lord","year":"2019","unstructured":"Lord J et al (2019) Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 393:747\u2013757. https:\/\/doi.org\/10.1016\/s0140-6736(18)31940-8","journal-title":"Lancet"},{"key":"2088_CR45","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.fertnstert.2015.07.1166","volume":"104","author":"J Martin","year":"2015","unstructured":"Martin J et al (2015) Comprehensive carrier genetic test using next-generation deoxyribonucleic acid sequencing in infertile couples wishing to conceive through assisted reproductive technology. Fertil Steril 104:1286\u20131293. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.07.1166","journal-title":"Fertil Steril"},{"key":"2088_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s40478-014-0148-0","volume":"2","author":"AB McKie","year":"2014","unstructured":"McKie AB et al (2014) Germline mutations in RYR1 are associated with foetal akinesia deformation sequence\/lethal multiple pterygium syndrome. Acta Neuropathol Commun 2:148. https:\/\/doi.org\/10.1186\/s40478-014-0148-0","journal-title":"Acta Neuropathol Commun"},{"key":"2088_CR47","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41431-018-0324-y","volume":"27","author":"N Meier","year":"2019","unstructured":"Meier N et al (2019) Exome sequencing of fetal anomaly syndromes: novel phenotype-genotype discoveries. Eur J Hum Genet 27:730\u2013737. https:\/\/doi.org\/10.1038\/s41431-018-0324-y","journal-title":"Eur J Hum Genet"},{"key":"2088_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.3438","author":"L Meng","year":"2017","unstructured":"Meng L et al (2017) Use of exome sequencing for infants in intensive care units: ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatr. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.3438","journal-title":"JAMA Pediatr"},{"key":"2088_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.fertnstert.2017.12.010","volume":"109","author":"EA Normand","year":"2018","unstructured":"Normand EA, Alaimo JT, Van den Veyver IB (2018a) Exome and genome sequencing in reproductive medicine. Fertil Steril 109:213\u2013220. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.12.010","journal-title":"Fertil Steril"},{"key":"2088_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13073-018-0582-x","volume":"10","author":"EA Normand","year":"2018","unstructured":"Normand EA et al (2018b) Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder genome medicine 10:74. https:\/\/doi.org\/10.1186\/s13073-018-0582-x","journal-title":"Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder genome medicine"},{"key":"2088_CR51","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0140-6736(18)32042-7","volume":"393","author":"S Petrovski","year":"2019","unstructured":"Petrovski S et al (2019) Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 393:758\u2013767. https:\/\/doi.org\/10.1016\/S0140-6736(18)32042-7","journal-title":"Lancet"},{"key":"2088_CR52","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1201569","volume":"367","author":"UM Reddy","year":"2012","unstructured":"Reddy UM et al (2012) Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med 367:2185\u20132193. https:\/\/doi.org\/10.1056\/NEJMoa1201569","journal-title":"N Engl J Med"},{"key":"2088_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.11.001","author":"M Rezaei","year":"2018","unstructured":"Rezaei M et al (2018) A reappraisal of circulating fetal cell noninvasive prenatal testing. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2018.11.001","journal-title":"Trends Biotechnol"},{"key":"2088_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"2088_CR55","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1373\/clinchem.2015.243667","volume":"61","author":"N Rifai","year":"2015","unstructured":"Rifai N, Topol E, Chan E, Lo YM, Wittwer CT (2015) Disruptive innovation in laboratory medicine. Clin Chem 61:1129\u20131132. https:\/\/doi.org\/10.1373\/clinchem.2015.243667","journal-title":"Clin Chem"},{"key":"2088_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40778-018-0118-8","volume":"4","author":"R Sagar","year":"2018","unstructured":"Sagar R, Walther-Jallow L, David AL, G\u00f6therstr\u00f6m C, Westgren M (2018) Fetal mesenchymal stromal cells: an opportunity for prenatal cellular therapy. Curr Stem Cell Rep 4:61\u201368. https:\/\/doi.org\/10.1007\/s40778-018-0118-8","journal-title":"Curr Stem Cell Rep"},{"key":"2088_CR57","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1056\/NEJMoa1714322","volume":"378","author":"H Schneider","year":"2018","unstructured":"Schneider H et al (2018) Prenatal correction of X-linked hypohidrotic ectodermal dysplasia. N Engl J Med 378:1604\u20131610. https:\/\/doi.org\/10.1056\/NEJMoa1714322","journal-title":"N Engl J Med"},{"key":"2088_CR58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1804134115","author":"K Sun","year":"2018","unstructured":"Sun K et al (2018) Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. Proc Natl Acad Sci USA. https:\/\/doi.org\/10.1073\/pnas.1804134115","journal-title":"Proc Natl Acad Sci USA"},{"key":"2088_CR59","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejogrb.2018.09.013","volume":"230","author":"N Suzumori","year":"2018","unstructured":"Suzumori N et al (2018) Compound heterozygous RYR1 mutations by whole exome sequencing in a family with three repeated affected fetuses with fetal akinesia. Eur J Obstet Gynecol Reprod Biol 230:200\u2013202. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.09.013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2088_CR60","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/GIM.0b013e318176fabb","volume":"10","author":"HV Toriello","year":"2008","unstructured":"Toriello HV, Meck JM, Professional P, Guidelines C (2008) Statement on guidance for genetic counseling in advanced paternal age. Genet Med 10:457\u2013460. https:\/\/doi.org\/10.1097\/GIM.0b013e318176fabb","journal-title":"Genet Med"},{"key":"2088_CR61","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/pd.5150","volume":"37","author":"EM Vestergaard","year":"2017","unstructured":"Vestergaard EM et al (2017) On the road to replacing invasive testing with cell-based NIPT: five clinical cases with aneuploidies, microduplication, unbalanced structural rearrangement or mosaicism. Prenat Diagn 37:1120\u20131124. https:\/\/doi.org\/10.1002\/pd.5150","journal-title":"Prenat Diagn"},{"key":"2088_CR62","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41436-018-0087-4","volume":"20","author":"NL Vora","year":"2018","unstructured":"Vora NL, Hui L (2018) Next-generation sequencing and prenatal \u2018omics: advanced diagnostics and new insights into human development. Genet Med 20:791\u2013799. https:\/\/doi.org\/10.1038\/s41436-018-0087-4","journal-title":"Genet Med"},{"key":"2088_CR63","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/gim.2017.33","volume":"19","author":"NL Vora","year":"2017","unstructured":"Vora NL et al (2017) Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges. Genet Med 19:1207\u20131216. https:\/\/doi.org\/10.1038\/gim.2017.33","journal-title":"Genet Med"},{"key":"2088_CR64","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/pd.5377","volume":"38","author":"L Vossaert","year":"2018","unstructured":"Vossaert L et al (2018) Reliable detection of subchromosomal deletions and duplications using cell-based noninvasive prenatal testing. Prenat Diagn 38:1069\u20131078. https:\/\/doi.org\/10.1002\/pd.5377","journal-title":"Prenat Diagn"},{"key":"2088_CR65","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","volume":"367","author":"RJ Wapner","year":"2012","unstructured":"Wapner RJ et al (2012) Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367:2175\u20132184. https:\/\/doi.org\/10.1056\/NEJMoa1203382","journal-title":"N Engl J Med"},{"issue":"102","key":"2088_CR66","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.ajog.2015.04.005","volume":"213","author":"J Williams 3rd","year":"2015","unstructured":"Williams J 3rd, Rad S, Beauchamp S, Ratousi D, Subramaniam V, Farivar S, Pisarska MD (2015) Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing. Am J Obstet Gynecol 213(102):e101\u2013106. https:\/\/doi.org\/10.1016\/j.ajog.2015.04.005","journal-title":"Am J Obstet Gynecol"},{"key":"2088_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/uog.15820","volume":"47","author":"CB Wulff","year":"2016","unstructured":"Wulff CB, Gerds TA, Rode L, Ekelund CK, Petersen OB, Tabor A, Danish Fetal Medicine Study G (2016) Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies. Ultrasound Obstet Gynecol 47:38\u201344. https:\/\/doi.org\/10.1002\/uog.15820","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2088_CR68","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","volume":"312","author":"Y Yang","year":"2014","unstructured":"Yang Y et al (2014) Molecular findings among patients referred for clinical whole-exome sequencing. JAMA 312:1870\u20131879. https:\/\/doi.org\/10.1001\/jama.2014.14601","journal-title":"JAMA"},{"key":"2088_CR69","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41591-018-0334-x","volume":"25","author":"J Zhang","year":"2019","unstructured":"Zhang J et al (2019) Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med 25:439\u2013447. https:\/\/doi.org\/10.1038\/s41591-018-0334-x","journal-title":"Nat Med"}],"container-title":["Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-019-02088-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00439-019-02088-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00439-019-02088-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T20:48:58Z","timestamp":1605818938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00439-019-02088-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,21]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2088"],"URL":"https:\/\/doi.org\/10.1007\/s00439-019-02088-4","relation":{},"ISSN":["0340-6717","1432-1203"],"issn-type":[{"value":"0340-6717","type":"print"},{"value":"1432-1203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,21]]},"assertion":[{"value":"5 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"RS has no conflicts to declare. IVdV conducts research on prenatal genome sequencing research that receives support from Illumina.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}